George Church of Harvard to present at the 13th Aging Research & Drug Discovery (ARDD) meeting in Boston
Meeting Announcement
Updates every hour. Last Updated: 30-Oct-2026 21:16 ET (31-Oct-2026 01:16 GMT/UTC)
ARDD 2026 has announced that George Church, Professor at Harvard Medical School, will speak at the 13th Aging Research & Drug Discovery (ARDD) Meeting, taking place October 1–3, 2026, at the David Rubenstein Treehouse at Harvard University. As the world's leading conference dedicated to longevity biotechnology, ARDD 2026 will convene top researchers, pharmaceutical executives, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines.
Organized by Insilico Medicine and supported by industry leaders including Eli Lilly and the McKinsey Health Institute, the meeting reflects the growing momentum behind longevity as a major frontier in biomedical innovation. With speakers representing ten of the world's leading pharmaceutical companies, ARDD 2026 aims to foster the collaborations needed to transform discoveries in aging biology into therapies that extend healthy lifespan and improve patient outcomes.
The narwhal’s impressive tusk has long been the subject of myths. In the Middle Ages, they were sold as unicorn horns believed to possess magical powers. Now, an international team of researchers led by Aarhus University has solved the mystery of how the tusk acquires its twisted structure. It turns out that the tooth does not contain just one spiral, but two.
A study of 21 adults receiving seasonal influenza vaccination found that pre-existing antibody levels were associated with distinct B-cell responses. Individuals with different baseline antibody levels showed differences in B-cell receptor features and antibody breadth after vaccination. The findings provide new insights into how pre-existing immunity may influence responses to influenza vaccination.